Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Updated Understanding of the Degenerative Disc Diseases - Causes versus Effects - Treatments, Studies and Hypothesis.

Muresanu C, Somasundaram SG, Neganova ME, Bovina EV, Vissarionov SV, Ofodile ONFC, Fisenko VP, Bragin V, Minyaeva NN, Chubarev VN, Klochkov SG, Tarasov VV, Kirkland CE, Aliev G.

Curr Top Med Chem. 2019 Nov 13. doi: 10.2174/1568026619666191114113048. [Epub ahead of print]

PMID:
31724500
2.

Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease.

Palacios HH, Yendluri BB, Parvathaneni K, Shadlinski VB, Obrenovich ME, Leszek J, Gokhman D, Gąsiorowski K, Bragin V, Aliev G.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):149-62. Review.

PMID:
21222631
3.

Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease.

Aliev G, Palacios HH, Gasimov E, Obrenovich ME, Morales L, Leszek J, Bragin V, Solís Herrera A, Gokhman D.

Pharmaceuticals (Basel). 2010 Jan 19;3(1):158-187. Review.

4.

Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease.

Aliev G, Palacios HH, Lipsitt AE, Fischbach K, Lamb BT, Obrenovich ME, Morales L, Gasimov E, Bragin V.

Neurotox Res. 2009 Oct;16(3):293-305. doi: 10.1007/s12640-009-9066-5. Epub 2009 May 30.

PMID:
19526276
5.

Integrated treatment approach improves cognitive function in demented and clinically depressed patients.

Bragin V, Chemodanova M, Dzhafarova N, Bragin I, Czerniawski JL, Aliev G.

Am J Alzheimers Dis Other Demen. 2005 Jan-Feb;20(1):21-6.

PMID:
15751450

Supplemental Content

Loading ...
Support Center